Promoter holding
64.27%
GT
Glamyo Technologies Private Limited - Due diligence report
A 360° intelligence report on Glamyo Health: trust score, financial health, credit view, compliance, directors, growth and distress signals …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Glamyo Health — 360° Intelligence Report
Generated from MCA filings & public records56/100
Trust Score
Moderate
Glamyo Health is assessed as Moderate with a Trust Score of 56/100. Glamyo Health is an active private limited indian non-government company incorporated in 2019, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.
Report generated on 17 Aug 2026 from the latest processed filings. Glamyo Technologies Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
56/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
67/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
20/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
85/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
35/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 3 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
Charges position: 1 open (10.00 cr) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 1 | 48.0 cr |
Compliance Score: 67/100 Moderate
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2022 - filings overdue.
- Delayed payments to MSME suppliers disclosed (1 disclosure(s)).
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 85/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SWATI GARG | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ARCHIT GARG | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- 1 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2022)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2022 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
15 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 85 · Distress 35
Growth signals & trust indicators
Revenue acceleration: +38% over 2 year(s).
Latest year revenue grew 1.42.
Asset base grew 2.1x - capacity expansion.
Operating for 6 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
Outside liabilities up 24% in a year.
Negative net worth.
Statutory filings appear overdue.
1 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 32,400.00.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence54/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 4 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment41/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 10.00 cr already registered.
- Compliance gaps should be priced into terms.
Investor view55/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events01 Oct 2025
Director ceased
PRIT PAL
25 Sep 2025
Director appointed
SWATI GARG (Additional Director)
15 May 2023
Director ceased
PRASHANT NARANG
19 Dec 2022
Charge created
Others - 10.00 cr
01 Oct 2022
Securities allotted
500 Debentures - 5.00 cr raised
29 Sep 2022
Last AGM held
Annual general meeting
27 Sep 2022
Securities allotted
598 Preference Shares - 4.90 cr raised
10 May 2022
Securities allotted
500 Debentures - 5.00 cr raised
06 May 2022
Securities allotted
5337 Preference Shares - 20.08 cr raised
31 Mar 2022
Latest balance sheet
Filed with ROC
21 Oct 2021
Securities allotted
2272 Preference Shares - 8.55 cr raised
10 Sep 2021
Securities allotted
314 Preference Shares - 91.06 Lakh raised
21 Aug 2021
Securities allotted
766 Preference Shares - 2.22 cr raised
17 Jun 2021
Securities allotted
529 Preference Shares - 1.53 cr raised
15 Apr 2021
Securities allotted
217 Preference Shares - 62.93 Lakh raised
10
Key Observations
Auto-generated from the data aboveRevenue grew 0.86 over the last 2 financial year(s).
Net profit margin moved from 61% to 38%.
2 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 15 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Sree Netralaya | U93030TG2010PTC067709 | Hyderabad, Telangana, India |
| Joy Imaging Private Limited | U93090MH2007PTC168538 | Mumbai, Maharashtra, India |
| Shri Bhagatji Surgicals Private Limited | U33208UP2019PTC112363 | Dadri, Uttar Pradesh, India |
| Kishan Singh Hospital | U74120HR2008PLC037760 | Faridabad, Haryana, India |
| The Oxygen Equipment & Engineering Company Private Limited | U29241TG1960PTC000861 | Andhra Pradesh, Telangana, India |
| Konacc Diagnostics Private Limited | U85110AP2008PTC061013 | Vijayawada, Andhra Pradesh, India |
| Bharath Healthcare Laboratories Private Limited | U74999TG2016PTC113063 | Hyderabad, Telangana, India |
| Binayak Imaging & Diagnostic Private Limited | U85195WB2003PTC095752 | Kolkata, West Bengal, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Glamyo Health before audits and certifications: compliance score 67/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Glamyo Health: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 85/100, margin trends, ownership structure and peer set for Glamyo Health - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 56/100, distress signals and MSME payment-delay disclosures - know whether Glamyo Health pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Glamyo Health - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Glamyo Health an active company?
Glamyo Health has MCA status “Active” with a compliance score of 67/100 (Moderate).
Is Glamyo Health financially healthy?
Glamyo Health has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Glamyo Health?
Its overall Trust Score is 56/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Glamyo Health?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Glamyo Health have loans or charges against its assets?
1 open charge(s) are registered against its assets.
Is Glamyo Health up to date with its ROC filings?
Last balance sheet is for Mar 2022 - filings overdue. Overall compliance score: 67/100 (Moderate).
Is it risky to lend to Glamyo Health?
Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
